Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

ADMA
ADMA Biologics, Inc.
stock NASDAQ

At Close
Jul 28, 2026 3:59:58 PM EDT
8.78USD+3.597%(+0.30)2,171,913
8.76Bid   10.00Ask   1.24Spread
Pre-market
Jul 27, 2026 9:27:30 AM EDT
8.37USD+1.209%(+0.10)0
After-hours
Jul 27, 2026 4:01:30 PM EDT
8.48USD-0.118%(-0.01)0
OverviewOption ChainMax PainOptionsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 19, 2022
07:40AM EST  The Daily Biotech Pulse: Gamida Gains On Positive Regulatory Development, Orphazyme & ADMA Preannouncements, ImmunityBio & Leap Present Positive Data   Benzinga
07:23AM EST  ADMA Biologics Sees Prelim. Q4 Revenues $26M vs $21.76M Est.   Benzinga
07:00AM EST  Fourth Quarter 2021 Preliminary Unaudited Total Revenues of Approximately $26 Million, the Highest Quarterly Revenue for the Company Since Inception   GlobeNewswire Inc
Jan 18, 2022
07:29AM EST  ADMA BioCenters Receives FDA Approval For Its Fourth Plasma Collection Center Located In Goose Creek, SC   Benzinga
07:00AM EST  ADMA BioCenters Receives FDA Approval for its Fourth Plasma   GlobeNewswire Inc
Dec 21, 2021
07:00AM EST  ADMA Biologics Adopts Limited Duration Stockholder Rights Plan   GlobeNewswire Inc
Dec 9, 2021
09:45PM EST  ADMA Biologics Provides Update On Global Intellectual Property Portfolio   Benzinga
07:00AM EST  Extends Existing U.S. Patent with Granted European Patent for Treatment and Prevention of S. Pneumococcal Infections with a Hyperimmune Globulin   GlobeNewswire Inc
Nov 17, 2021
07:00AM EST  ADMA Biologics Senior Vice President of Plasma Services Cyndi   GlobeNewswire Inc
Nov 16, 2021
07:11AM EST  ADMA Biologics Expands Plasma Collection Plans With Opening of New Facility in Myrtle Beach, SC   Benzinga
07:00AM EST  ADMA Biologics, Inc. (NASDAQ: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters location in Myrtle Beach, South Carolina.   GlobeNewswire Inc
Nov 11, 2021
10:01AM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021   Benzinga
07:26AM EST  Raymond James Upgrades ADMA Biologics to Strong Buy, Announces $5 Price Target   Benzinga
Nov 10, 2021
04:08PM EST  ADMA Biologics Q3 EPS $(0.13) Beats $(0.14) Estimate, Sales $20.70M Beat $18.72M Estimate   Benzinga
04:01PM EST  Generated Record Total Revenues of $20.7 Million in the Third Quarter 2021, a 101% Increase Over Third Quarter 2020   GlobeNewswire Inc
08:23AM EST  The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance   Benzinga
04:09AM EST  Earnings Scheduled For November 10, 2021   Benzinga
Nov 9, 2021
12:07PM EST  Preview: ADMA Biologics's Earnings   Benzinga
12:02PM EST  Benzinga's Top Ratings Upgrades, Downgrades For November 9, 2021   Benzinga
11:24AM EST  Cantor Fitzgerald Initiates Coverage On ADMA Biologics with Overweight Rating, Announces Price Target of $4.5   Benzinga
Nov 3, 2021
07:00AM EDT  ADMA Biologics to Report Third Quarter 2021 Financial Results on   GlobeNewswire Inc
Oct 26, 2021
08:17AM EDT  Raymond James Maintains Outperform on ADMA Biologics, Lowers Price Target to $5   Benzinga
Oct 25, 2021
04:01PM EDT  ADMA Biologics Announces Closing of $57.5 Million Public Offering   GlobeNewswire Inc
Oct 22, 2021
07:06AM EDT  ADMA Biologics Highlights Presentation Of Data At International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference Oct. 19-22   Benzinga
07:00AM EDT  ADMA Biologics Announces Data Presented at the 2021 ISIRV-WHO   GlobeNewswire Inc
Oct 21, 2021
12:12PM EDT  ADMA Biologics Prices 50M Shares At $1/Share   Benzinga
12:11PM EDT  The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO   Benzinga
12:10PM EDT  ADMA Biologics Reports Offering Of Common Stock, No Size Disclosed   Benzinga
09:00AM EDT  ADMA Biologics Announces Pricing of Public Offering for $50   GlobeNewswire Inc
06:17AM EDT  The following are some of the stocks making big moves in Thursday's pre-market trading (as of 06.05 A.M. EDT).   RTTNews
Oct 20, 2021
04:01PM EDT  ADMA Biologics Announces Proposed Public Offering of Common Stock   GlobeNewswire Inc
Oct 19, 2021
07:26AM EDT  ADMA Biologics Announces A Poster Presentation At The 2021 International Society For Influenza And Other Respiratory Virus Diseases - World Health Organization Conference   Benzinga
07:00AM EDT  ADMA Biologics Announces a Poster Presentation at the 2021   GlobeNewswire Inc
Oct 18, 2021
07:00AM EDT  ADMA Biologics Strengthens its Board of Directors with the   GlobeNewswire Inc
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
Oct 7, 2021
12:53PM EDT  ADMA Biologics Sponsored Study Titled 'An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)' Posted To ClinicalTrials.gov   Benzinga
Oct 4, 2021
07:17AM EDT  ADMA Biologics Highlights Presentation Of Real-World Experience In Management Of Respiratory Syncytial Virus Presented At IDWeek 2021   Benzinga
07:00AM EDT  ADMA Biologics Announces the Presentation of Real-World Experience   GlobeNewswire Inc
Oct 1, 2021
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
07:00AM EDT  ADMA Biologics Announces Presentation on Respiratory Viral   GlobeNewswire Inc
Sep 30, 2021
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 27, 2021
12:36PM EDT  ADMA Biologics's Return On Capital Employed Overview   Benzinga
Sep 23, 2021
07:00AM EDT  ADMA Biologics to Virtually Participate in the Cantor Healthcare   GlobeNewswire Inc
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 9, 2021
10:24AM EDT  ADMA Biologics Shares Spike On Volume, Co. Files U.S. Patent Application For 'IMMUNOTHERAPEUTIC COMPOSITIONS AND METHODS OF PRODUCTION FOR CORONAVIRUS'   Benzinga
Sep 8, 2021
12:43PM EDT  ADMA Biologics shares were trading higher after the company announced it received FDA approval for VanRx aseptic fill-finish machine and related operations.   Benzinga
08:51AM EDT  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Sept. 8, 2021: KR, COUP, ADMA, UPST, NIO   Benzinga
08:13AM EDT  ADMA Biologics Announces FDA Approval Of VanRx Fill-finish   RTTNews
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
07:23AM EDT  ADMA Biologics Gets FDA Approval For VanRx Aseptic Fill-Finish Machine   RTTNews
07:07AM EDT  ADMA Biologics Receives FDA Approval For VanRx Aseptic Fill-Finish Machine And Related Operations   Benzinga
07:00AM EDT  Expected to Provide Improved Gross Margins, Enhanced Patient Supply Consistency, Accelerated Inventory Production Cycle Time and Increased Control and Visibility of Commercial Product Lot Releases   GlobeNewswire Inc
Sep 2, 2021
07:00AM EDT  ADMA Biologics to Virtually Participate in the Morgan Stanley 19th   GlobeNewswire Inc
Aug 20, 2021
07:45AM EDT  The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data   Benzinga
Aug 19, 2021
10:57AM EDT  The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck   Benzinga
Aug 18, 2021
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 16, 2021
03:27PM EDT  ADMA Biologics shares were trading higher after the company announced it received FDA approval for ADMA BioCenters Plasma Collection facility in Maryville, TN.   Benzinga
07:02AM EDT  ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN   Benzinga
07:00AM EDT  ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma   GlobeNewswire Inc
Aug 12, 2021
06:32AM EDT  HC Wainwright & Co. Maintains Buy on ADMA Biologics, Lowers Price Target to $6   Benzinga
Aug 11, 2021
04:28PM EDT  ADMA Biologics Q2 EPS ~$(0.15), Inline, Sales ~$17.80M Beat $16.42M Estimate   Benzinga
04:05PM EDT  Achieved Record Total Revenues of $17.8 Million in Second Quarter 2021, a 129% Increase Over Second Quarter 2020   GlobeNewswire Inc
09:06AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
08:14AM EDT  The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering   Benzinga
04:27AM EDT  Earnings Scheduled For August 11, 2021   Benzinga
Aug 10, 2021
04:50PM EDT  ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics' Persona Technology for NexSys Plasma Collection System   Benzinga
10:45AM EDT  ADMA Biologies Granted U.S. Patent Titled 'Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection'   Benzinga
Aug 9, 2021
11:07AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
07:00AM EDT  ADMA Expands Commercial IG Product Offering with Additional BIVIGAM and NABI-HB Vial Sizes   GlobeNewswire Inc
Aug 8, 2021
10:11AM EDT  The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight   Benzinga
Aug 4, 2021
07:00AM EDT  ADMA Biologics to Report Second Quarter 2021 Financial Results on   GlobeNewswire Inc
Jul 20, 2021
07:06AM EDT  ADMA Biologics reports Successful Completion Of Its FDA Pre-Approval Manufacturing Facility Inspection   Benzinga
07:06AM EDT  ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection   Benzinga
07:00AM EDT  Approval for VanRx Fill-Finish Machine Expected in the Second Half of 2021   GlobeNewswire Inc
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 6, 2021
08:15AM EDT  10 Biggest Price Target Changes For Tuesday   Benzinga
06:31AM EDT  HC Wainwright & Co. Maintains Buy on ADMA Biologics, Lowers Price Target to $7   Benzinga
Jun 14, 2021
07:00AM EDT  ADMA Biologics to Participate in the Raymond James Human Health   GlobeNewswire Inc
Jun 1, 2021
07:05AM EDT  A Peek Into The Markets: US Stock Futures Gain Ahead of Manufacturing Data   Benzinga
May 28, 2021
04:50PM EDT  ADMA Biologics Announces $50M Offering   Benzinga
11:08AM EDT  ROCE Insights For ADMA Biologics   Benzinga
May 26, 2021
07:00AM EDT  ADMA Biologics, Inc. (Nasdaq: ADMA) (the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on June 2, 2021 at 4:00 p.m. ET.   GlobeNewswire Inc
May 13, 2021
01:26PM EDT  ADMA Biologics shares shares were trading higher after the company reported better-than-expected Q1 EPS and sales results.   Benzinga
May 12, 2021
05:05PM EDT  Recap: ADMA Biologics Q1 Earnings   Benzinga
04:48PM EDT  ADMA Biologics Q1 EPS $(0.16) Beats $(0.17) Estimate, Sales $16.00M Beat $14.58M Estimate   Benzinga
04:05PM EDT  Achieved First Quarter 2021 Total Revenues of $16.0 Million, a 57% Increase Over First Quarter 2020   GlobeNewswire Inc
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
04:22AM EDT  Earnings Scheduled For May 12, 2021   Benzinga
May 11, 2021
10:17AM EDT  ADMA Biologics Earnings Preview   Benzinga
May 5, 2021
07:00AM EDT  ADMA Biologics to Report First Quarter 2021 Financial Results on   GlobeNewswire Inc
Apr 28, 2021
08:41AM EDT  ADMA Biologics Shares Jump On Increased Manufacturing Capacity For Intravenous Immune Globulin   Benzinga
07:05AM EDT  ADMA Biologics Says Receives FDA Approval For Increased IVIG Production Scale   Benzinga
07:00AM EDT  ADMA Increases Total Forecasted Plant Manufacturing Capacity from 400,000 Liters up to 600,000 Liters and Increases Total Forecasted Peak Revenues in Excess of $300 Million   GlobeNewswire Inc
Apr 26, 2021
08:00AM EDT  ADMA Biologics, Inc. (NASDAQ: ADMA) (ADMA), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced commencement of operations and initiation of donor plasma collections at its newest ADMA BioCenters plasma collection facility located in Goose Creek, South Carolina.   GlobeNewswire Inc
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 20, 2021
08:07AM EDT  The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex   Benzinga
Apr 13, 2021
08:04AM EDT  ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting   Benzinga
08:00AM EDT  Poster Presentation Highlights the Unmet Patient Need and Medical Cost Burden Associated with Hepatitis B Infection   GlobeNewswire Inc
Mar 31, 2021
07:41AM EDT  The Daily Biotech Pulse: Pfizer Vaccine 100% Effective In Adolescents, Equillium Readout, Amgen Goes Shopping, Achilles IPO   Benzinga
Mar 26, 2021
07:45AM EDT  Raymond James Maintains Outperform on ADMA Biologics, Lowers Price Target to $6   Benzinga
Mar 25, 2021
04:08PM EDT  ADMA Biologics Says Revises Previous Guidance From Building 5-10 Plasma Collection Facilities By 2024 To Current Expectation Of Having 10 Or More Plasma Collection Facilities In Operation By 2024   Benzinga
04:06PM EDT  ADMA Biologics Q4 EPS $(0.20) Misses $(0.16) Estimate, Sales $13.96M Beat $12.91M Estimate   Benzinga
04:05PM EDT  Achieved Full Year 2020 Total Revenues of $42.2 Million, a 44% Increase Over Full Year 2019   GlobeNewswire Inc
07:58AM EDT  The Daily Biotech Pulse: Bristol-Myers Squibb's Skin Cancer Readout, Cellect Strikes Reverse Merger Deal, Lava Therapeutics Makes Nasdaq Debut   Benzinga
04:03AM EDT  Earnings Scheduled For March 25, 2021   Benzinga
Mar 18, 2021
08:00AM EDT  ADMA Biologics to Report Fourth Quarter and Full Year 2020   GlobeNewswire Inc
Mar 4, 2021
08:00AM EST  ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit   GlobeNewswire Inc
Mar 3, 2021
08:03AM EST  ADMA Biologics Says FDA Approves Commence Hepatitis B Plasma Collections   Benzinga
08:00AM EST  ADMA Biologics Expands Global Regulatory Approval Presence and   GlobeNewswire Inc
05:20AM EST  COVID-19 Convalescent Plasma Study Shows No Benefit, US NIH Stops Trial   Benzinga
Feb 26, 2021
08:04AM EST  ADMA Biologics Highlights Presenting Of Late-Breaking Poster On Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting Feb. 26-Mar. 1, 2021   Benzinga
08:00AM EST  Poster Presentation Highlights the Need for a Polyclonal Hyperimmune Globulin Targeting S. Pneumoniae to Bridge Vaccination and Seroconversion Across Multiple Serotypes   GlobeNewswire Inc
Feb 22, 2021
08:00AM EST  ADMA Biologics to Participate in Raymond James Institutional   GlobeNewswire Inc
Feb 1, 2021
08:11AM EST  ADMA Biologics Receives FDA Approval For ADMA BioCenters Plasma Collection Facility In Knoxville   RTTNews
08:00AM EST  ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma   GlobeNewswire Inc
Jan 26, 2021
08:04AM EST  ADMA Biologics Says Receives Unique Permanent J-Code For ASCENIV   Benzinga
08:00AM EST  ADMA Biologics Receives Unique Permanent J-Code for   GlobeNewswire Inc
Jan 19, 2021
08:10AM EST  ADMA Biologics Sees Q4 2020 Revs $13.9M Vs Est $12.05M   Benzinga
08:00AM EST  Achieved Fourth Quarter 2020 Preliminary Unaudited Total Revenues of $13.9 Million, the Highest Revenue Quarter for the Company Since Inception   GlobeNewswire Inc
Jan 4, 2021
08:13AM EST  ADMA Biologics Receives Temporary C-Code And Pass-Through Payment Status For ASCENIV From Centers For Medicare And Medicaid Services   Benzinga
08:00AM EST  ADMA Biologics Receives Unique Temporary C-Code and Pass-Through   GlobeNewswire Inc
06:15AM EST  HC Wainwright & Co. Maintains Buy on ADMA Biologics, Lowers Price Target to $11   Benzinga
Dec 16, 2020
04:16PM EST  ADMA Biologic Reports Adoption Of Limited Duration Shareholder Rights Plan   Benzinga
04:15PM EST  ADMA Biologics Adopts Limited Duration Stockholder Rights Plan   GlobeNewswire Inc
Dec 9, 2020
10:33AM EST  Return On Capital Employed Overview: ADMA Biologics   Benzinga
08:05AM EST  ADMA Biologics Reports $100M Credit Facility Loan Amendment With Perceptive Advisors: 'Increases Size of Facility and Extends Interest-Only Period...'   Benzinga
08:00AM EST  Increases Size of Facility and Extends Interest-Only Period Enabling ADMA to Reach Profitability Prior to Maturity   GlobeNewswire Inc
Dec 1, 2020
07:00AM EST  ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection   GlobeNewswire Inc
Nov 10, 2020
07:00AM EST  ADMA Biologics to Participate in Jefferies 2020 Virtual London   GlobeNewswire Inc
Nov 5, 2020
05:09PM EST  ADMA Biologics Q3 EPS $(0.19), Inline, Sales $10.28M Beat $9.96M Estimate   Benzinga
07:54AM EST  The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping   Benzinga
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 1, 2020
09:40AM EST  The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings   Benzinga
Oct 29, 2020
07:01AM EDT  ADMA Biologics to Report Third Quarter 2020 Financial Results and   GlobeNewswire Inc
Oct 21, 2020
07:00AM EDT  ADMA Biologics Announces Presentation on Respiratory Viral   GlobeNewswire Inc
Oct 1, 2020
08:58AM EDT  10 Biggest Price Target Changes For Thursday   Benzinga
07:17AM EDT  Raymond James Maintains Outperform on ADMA Biologics, Lowers Price Target to $7   Benzinga
Sep 14, 2020
11:56AM EDT  Insider Buys ADMA Biologics Stock   Benzinga
Sep 9, 2020
07:00AM EDT  ADMA Biologics to Participate in Morgan Stanley Virtual Healthcare   GlobeNewswire Inc
Sep 3, 2020
11:45AM EDT  ADMA Biologics shares are trading higher after the company announced the launch of COVID-19 ImmunoRank Neutralization MICRO-ELISA for the detection of SARS-CoV-2 neutralizing antibodies in plasma.   Benzinga
07:02AM EDT  ADMA Biologics Highlights Launch Of COVID-19 ImmunoRank Neutralization MICRO-ELISA For Use 'as an aid to identify individuals who produce an adaptive immune response to SARS-CoV-2'   Benzinga
07:00AM EDT  ImmunoRank Offers a Faster, Simpler, More Cost Effective Way to Identify High Titer Convalescent Plasma for Use in Both Treating COVID-19 Patients and for Creating COVID-19 Hyperimmune Globulins   GlobeNewswire Inc
Sep 2, 2020
07:00AM EDT  ADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that Adam Grossman, President and Chief Executive Officer, is scheduled to participate in the following upcoming investor conferences in September:   GlobeNewswire Inc
Aug 24, 2020
11:10AM EDT  Return On Capital Employed Overview: ADMA Biologics   Benzinga
10:32AM EDT  Shares of ADMA Biologics Inc. (ADMA) are higher by more than 24 percent or $0.62 in Monday's morning trade at $3.14.   RTTNews
08:32AM EDT  From Benzinga's PreMarket Prep: Co-Host Dennis Dick Says If He Was In Plasma Stocks Right Now He Would Sell Them; Notes 'This Is A Gift I Would Ring The Register Right Now'   Benzinga
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:19AM EDT  Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate   Benzinga
Aug 5, 2020
04:59PM EDT  ADMA Biologics Q2 EPS $(0.23) Misses $(0.16) Estimate, Sales $7.79M Miss $10.57M Estimate   Benzinga
04:05PM EDT  Generated Total Revenues of $18.0 Million for the First Half of 2020, Reflecting a 78% Increase Over First Half of 2019   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 5, 2020   Benzinga
Jul 30, 2020
10:40AM EDT  Shares of ADMA Biologics, Inc. (ADMA) are currently gaining over 37% on Thursday morning despite no stock related news to drive the shares.   RTTNews
Jul 29, 2020
07:00AM EDT  ADMA Biologics to Report Business Highlights and Second Quarter   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC